NASDAQ:ONTX Archives - BioPharmaJournal

Home Tags NASDAQ:ONTX

Onconova Therapeutics Inc (NASDAQ:ONTX) Doses The First Patient In Phase 2...

Gavins Felicity - May 19, 2021 0

Onconova Therapeutics Inc (NASDAQ:ONTX) Inducts Three Patients In The Phase 1...

Gavins Felicity - April 7, 2021 0

Onconova Therapeutics Inc. (NASDAQ:ONTX) Submits Investigational New Drug Application For ON...

Gavins Felicity - December 3, 2020 0

Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In...

Matt Wade - September 25, 2020 0

Onconova Therapeutics Inc (NASDAQ:ONTX) says the Pivotal Phase 3 INSPIRE trial...

Ward Sport - September 4, 2020 0

Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire...

Kate Hudson - August 25, 2020 0

Onconova Therapeutics Inc. NASDAQ:ONTX) Has Submitted an Application with the NIAID...

Kate Hudson - July 31, 2020 0

Onconova Therapeutics Inc. (NASDAQ:ONTX) Publishes Phase 1 Oral Rigosertib Combination With...

Kate Hudson - July 13, 2020 0

Onconova Therapeutics Inc. (NASDAQ:ONTX) Commence Enrolment in Phase 1/2a Rigosertib Plus...

Gavins Felicity - July 1, 2020 0

Recent Post

Invesco QQQ Trust Series 1 (QQQ) hits all time high and...

Kate Hudson - June 5, 2023 0

The QQQ’s made new 12 month highs again this morning, continuing to grind higher ahead of the FED meeting next week.

Banking stocks in focus

Stocks In focus ahead as Wall Street grows hopeful of a...

May 26, 2023

Best Stocks Alerts

Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3...

May 3, 2023

IPOs are starting to heat up again (TRNR,GNLX,TCJH)

May 1, 2023

TOP Financial Group Limited ($TOP) surges over 600% after market hours

April 27, 2023